The use of ronkolejkinin the complex therapyof the patientswith a relapseof HBeAg-negative chronic hepatitis B

Abstract


The article discusses the results of a comprehensive treatment of patients with a relapse of HBeAg-negative chronic hepatitis В. Presented using ;ronkolejkin in combination with lamivudine in this category of patients. Submissions studies indicate high efficiency destination this regimen for normalization of major clinical and biochemical and immunological indicators, repeat the patients with chronic hepatitis B.

About the authors

E A Melnikova

Email: foges@rambler.ru

References

  1. Шахгильдян И.В., Михайлов М.И. Эпидемиология вирусных гепатитов. Доклад на XII Российской конференции «Гепатология сегодня» 27 марта 2006 г.
  2. Kao J.I., Chen D.S. Global control of hepatic B virus infection. Lancet Infect. Dis., 2002, 2, 395-403.
  3. Lau J.Y., Wright T.L. Molecular virology and pathogenesis of hepatitis B. Lancet, 1993, 342, 1335-1340.

Statistics

Views

Abstract - 23

Cited-By


Article Metrics

Metrics Loading ...

PlumX

Dimensions

Refbacks

  • There are currently no refbacks.

Copyright (c) 2010 Melnikova E.A.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies